Navigate on publiceye.ch
Quick navigation
Content
Homepage
Navigation
Sitemap
Search
Main navigation
About us
Get involved
Our topics
Change category
#InvestigationAward
Pesticides
Fashion
Soft Commodities
Medicines
Commodities
Trade policy
Investigation Award
Seeds
Biopiracy
Archive
Close
Open search forn
Publications
en
Change language. Current language: English
Deutsch
Français
English
Close
Donate
Open menu
Search term
Search
Close search
Search term
Search
About us
Get involved
Our topics
Pesticides
Fashion
Soft Commodities
Medicines
Commodities
Trade policy
Investigation Award
Seeds
Biopiracy
Archive
Publications
Change language. Current language: English
DE
FR
EN
Close menu
Tag
Medicines
16
th
Dec
Victory for public health
Novartis drops the Kymriah patent that was opposed by Public Eye
16 December 2019
3
rd
July
Affordable drugs
Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent
3 July 2019
20
th
May
Report
Post-Trial Access to Swiss Medicines
2019
20
th
May
Clinical trials
Roche and Novartis neglect their ethical responsibility in emerging countries
20 May 2019
11
th
Apr
Panel discussion
No fair pricing without transparency
11 April 2019
6
th
Nov
News
Stop TRIPS-plus measures in trade agreement with Indonesia
6 November 2018
13
th
Sept
Press Release
33,000 signatures: curb the exorbitant cost of medicines
13 September 2018
21
st
May
Report
Protect patients, not patents
2018
12
th
Apr
Press Release
Compulsory licensing in Colombia: Aggressive lobbying by Novartis
12 April 2017
30
th
Sept
Report
Clinical Drug Trials: Conference Report 2016
2016
1
2
3
4
Your continued use of our website implies that you acknowledge the use of cookies.
More infos about this in our privacy statement.
